Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Morgenstern

Showing results (51-60 of 179) with videos related to

Pageof 18
Sort By:
Antimicrobial Agents and Chemotherapy|January 14, 2009
Radioimmunotherapy is effective against high-inoculum Cryptococcus neoformans infection in mice and does not select for radiation-resistant cryptococcal cellsRuth A Bryan, Zewei Jiang, Xianchun Huang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 30, 2020
First patient exceeding 5-year complete remission after <sup>225</sup>Ac-PSMA-TATHendrik Rathke, Frank Bruchertseifer, Clemens Kratochwil, et al.
Plos One|July 22, 2017
In Vitro comparison of 213Bi- and 177Lu-radiation for peptide receptor radionuclide therapyHo Sze Chan, Erik de Blois, Alfred Morgenstern, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 6, 2024
Deescalated <sup>225</sup>Ac-PSMA-617 Versus <sup>177</sup>Lu/<sup>225</sup>Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 PatientsHendrik Rathke, Erik Winter, Frank Bruchertseifer, et al.
Angewandte Chemie (International Ed. in English)|February 11, 2011
Magnetic memory effect in a transuranic mononuclear complexNicola Magnani, Christos Apostolidis, Alfred Morgenstern, et al.
Cancer Science|June 15, 2007
213Bi-radioimmunotherapy defeats early-stage disseminated gastric cancer in nude miceRoswitha Beck, Christof Seidl, Birgit Pfost, et al.
Molecular Cancer Therapeutics|July 23, 2013
Targeting aberrant DNA double-strand break repair in triple-negative breast cancer with alpha-particle emitter radiolabeled anti-EGFR antibodyHong Song, Mohammad Hedayati, Robert F Hobbs, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 13, 2012
Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosisMarkus Essler, Florian C Gärtner, Frauke Neff, et al.
Immunotherapy|September 15, 2011
Analysis of patient survival in a Phase I trial of systemic targeted α-therapy for metastatic melanomaBarry J Allen, Apresh A Singla, Syed M Abbas Rizvi, et al.
Molecular Cancer Therapeutics|November 21, 2015
Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial AnaloguesCharles Zhu, Amey Bandekar, Michelle Sempkowski, et al.
Pageof 18

Showing results (51-60 of 179) with videos related to

Sort By:
Pageof 18
Antimicrobial Agents and Chemotherapy|January 14, 2009
Radioimmunotherapy is effective against high-inoculum Cryptococcus neoformans infection in mice and does not select for radiation-resistant cryptococcal cellsRuth A Bryan, Zewei Jiang, Xianchun Huang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 30, 2020
First patient exceeding 5-year complete remission after <sup>225</sup>Ac-PSMA-TATHendrik Rathke, Frank Bruchertseifer, Clemens Kratochwil, et al.
Plos One|July 22, 2017
In Vitro comparison of 213Bi- and 177Lu-radiation for peptide receptor radionuclide therapyHo Sze Chan, Erik de Blois, Alfred Morgenstern, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 6, 2024
Deescalated <sup>225</sup>Ac-PSMA-617 Versus <sup>177</sup>Lu/<sup>225</sup>Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 PatientsHendrik Rathke, Erik Winter, Frank Bruchertseifer, et al.
Angewandte Chemie (International Ed. in English)|February 11, 2011
Magnetic memory effect in a transuranic mononuclear complexNicola Magnani, Christos Apostolidis, Alfred Morgenstern, et al.
Cancer Science|June 15, 2007
213Bi-radioimmunotherapy defeats early-stage disseminated gastric cancer in nude miceRoswitha Beck, Christof Seidl, Birgit Pfost, et al.
Molecular Cancer Therapeutics|July 23, 2013
Targeting aberrant DNA double-strand break repair in triple-negative breast cancer with alpha-particle emitter radiolabeled anti-EGFR antibodyHong Song, Mohammad Hedayati, Robert F Hobbs, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 13, 2012
Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosisMarkus Essler, Florian C Gärtner, Frauke Neff, et al.
Immunotherapy|September 15, 2011
Analysis of patient survival in a Phase I trial of systemic targeted α-therapy for metastatic melanomaBarry J Allen, Apresh A Singla, Syed M Abbas Rizvi, et al.
Molecular Cancer Therapeutics|November 21, 2015
Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial AnaloguesCharles Zhu, Amey Bandekar, Michelle Sempkowski, et al.
Pageof 18